CPP and rheumatoid arthritis: The combination of high specificity (90–99%) and high sensitivity (66–88%) of anti-CPP for diagnosing RA, and above all, correlation with radiological damage has led to the conclusion that these antibodies have a pathological connection to the initiation of RA (185, 187–192).